Retrospective cohort study compares outcomes of chemoradiotherapy and induction chemoimmunotherapy in unresectable NSCLC, suggesting advantage for chemoradiotherapy.
Compared with ICT+RT, cCRT+IO demonstrated superior efficacy with a manageable safety profile in unresectable stage III NSCLC.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: